$20,000 is available for medical, scientific or social research to improve outcomes for people with haemophilia, von Willebrand disorder or other related inherited bleeding disorders, and/or those with medically acquired blood borne viruses.
The funding round is for research projects to commence in the 2016-2017 financial year.